行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

南方医药创新股票C(010593)

2026-09-29     0.62800.4639%
持仓重大变化
截止日期:  
 查询其他基金该项数据
序号 股票代码 股票简称 累计买入金额(万元) 占期初净值比例(%)
1688796百奥赛图11,501.486.61
2002821招商丰乐混合A8,437.594.85
3002821凯莱英8,437.594.85
402269药明生物8,373.264.81
502315百奥赛图-B8,364.234.81
6002422新华增强债券C8,070.094.64
7002422科伦药业8,070.094.64
8688202美迪西8,038.764.62
901093石药集团7,765.344.46
10002950华安丰利18个月定开债A6,967.424.00
11002950奥美医疗6,967.424.00
12603259药明康德6,615.283.80
13301580爱迪特6,357.163.65
14688331荣昌生物6,272.033.60
1509926康方生物6,153.753.54
16300677英科医疗5,638.193.24
17688266泽璟制药4,761.992.74
18002294博时新机遇混合C4,714.132.71
19002294信立泰4,714.132.71
20688301奕瑞科技4,552.752.62
21688356键凯科技4,345.732.50
22002755博时裕盛纯债债券A4,159.452.39
23002755奥赛康4,159.452.39
24603538美诺华4,041.362.32
2501548金斯瑞生物科技3,963.242.28
26688180君实生物3,895.292.24
2703759康龙化成3,783.702.17
28688293奥浦迈3,631.102.09
2902155森松国际3,624.562.08
30600276恒瑞医药3,579.162.06
序号 股票代码 股票简称 累计卖出金额(万元) 占期初净值比例(%)
101530三生制药10,101.335.80
2300677英科医疗9,646.145.54
3688266泽璟制药8,821.395.07
402315百奥赛图-B8,316.464.78
501801信达生物7,578.114.35
6688068热景生物7,475.884.30
702269药明生物7,218.544.15
801093石药集团6,998.024.02
9688796百奥赛图6,928.523.98
10301580爱迪特6,445.293.70
1101177中国生物制药6,331.283.64
1202268药明合联6,238.673.59
13002950华安丰利18个月定开债A6,188.663.56
14002950奥美医疗6,188.663.56
1502096先声药业6,116.353.51
16688513苑东生物6,105.993.51
1709926康方生物5,756.943.31
18600276恒瑞医药5,415.763.11
1909606映恩生物-B5,391.623.10
2006990科伦博泰生物5,369.913.09
2109995荣昌生物5,346.593.07
22688202美迪西5,054.532.90
23688382益方生物5,027.952.89
24688331荣昌生物4,567.612.62
25688506百利天恒4,453.582.56
26688301奕瑞科技4,209.952.42
27002294博时新机遇混合C4,056.932.33
28002294信立泰4,056.932.33
29002755博时裕盛纯债债券A3,818.792.19
30002755奥赛康3,818.792.19
3101548金斯瑞生物科技3,609.902.07
32301246宏源药业3,583.632.06